Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Establishment of a Novel Cancer-Specific Anti-HER2 Monoclonal Antibody H 2 Mab-250/H 2 CasMab-2 for Breast Cancers.

  • Authors : Kaneko MK; Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Japan.; Suzuki H

Subjects: Breast Neoplasms* ; Antineoplastic Agents*; Humans

  • Source: Monoclonal antibodies in immunodiagnosis and immunotherapy [Monoclon Antib Immunodiagn Immunother] 2024 Apr; Vol. 43 (2), pp. 35-43. Date of Electronic Publication: 2024 Apr 02.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101590955 Publication Model: Print-Electronic

Record details

×
Academic Journal

Cx 1 Mab-1: A Novel Anti-mouse CXCR1 Monoclonal Antibody for Flow Cytometry.

  • Authors : Li G; Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Japan.; Tanaka T

Subjects: Antibodies, Monoclonal* ; Neoplasms*; Cricetinae

  • Source: Monoclonal antibodies in immunodiagnosis and immunotherapy [Monoclon Antib Immunodiagn Immunother] 2024 Apr; Vol. 43 (2), pp. 59-66.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101590955 Publication Model: Print Cited

Record details

×
Academic Journal

Modulation of NRF2: Biological Dualism in Cancer, Targets and Possible Therapeutic Applications.

  • Authors : Gallorini M; Department of Pharmacy, University 'G. d'Annunzio' Chieti-Pescara, Chieti, Italy.; Carradori S

Subjects: Neoplasms*/Neoplasms*/Neoplasms*/drug therapy ; NF-E2-Related Factor 2*/NF-E2-Related Factor 2*/NF-E2-Related Factor 2*/metabolism; Humans

  • Source: Antioxidants & redox signaling [Antioxid Redox Signal] 2024 Apr; Vol. 40 (10-12), pp. 636-662. Date of Electronic Publication: 2023 Sep 06.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100888899 Publication Model: Print-Electronic

Record details

×
Academic Journal

Noninvasive Assessment of HER2 Expression Status in Gastric Cancer Using 18 F-FDG Positron Emission Tomography/Computed Tomography-Based Radiomics: A Pilot Study.

  • Authors : Jiang X; Department of Nuclear Medicine, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.; Li T

Subjects: Radiomics* ; Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/diagnostic imaging ; Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/genetics

  • Source: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2024 Apr; Vol. 39 (3), pp. 169-177. Date of Electronic Publication: 2024 Jan 09.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print-Electronic

Record details

×
Academic Journal

Unraveling Interaction of Rhenium-188 Microspheres with Primary Hepatic Cancer Cell: A Breakthrough Study.

  • Authors : Aggarwal A; Department of Nuclear Medicine, PGIMER Chandigarh, Chandigarh, India.; Kaur G

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/radiotherapy ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/metabolism ; Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/radiotherapy

  • Source: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2024 Apr; Vol. 39 (3), pp. 188-195. Date of Electronic Publication: 2024 Jan 19.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print-Electronic

Record details

×
Academic Journal

Lipiodol as a Predictive Indicator for Therapy Response to Transarterial Chemoembolization of Hepatocellular Carcinoma.

  • Authors : Langenbach MC; Institute for Diagnostic and Interventional Radiology, University Hospital Cologne, Cologne, Germany.; Institute for Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt, Germany.

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/diagnostic imaging ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/therapy ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/pathology

  • Source: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2024 Apr; Vol. 39 (3), pp. 196-202. Date of Electronic Publication: 2021 Jan 22.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print-Electronic

Record details

×
Academic Journal

Curcumol Inhibits the Progression of Hepatocellular Carcinoma by Regulating the Expression of hsa_circ_0028861.

  • Authors : Wu Y; Department of Hepatobiliary Surgery, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, People's Republic of China.; Tang H

Subjects: Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/drug therapy ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/genetics ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/metabolism

  • Source: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2024 Apr; Vol. 39 (3), pp. 203-210. Date of Electronic Publication: 2024 Jan 05.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print-Electronic

Record details

×
Academic Journal

The Regulatory Role of SNORD35A in Pancreatic Cancer Involves the HGF/C-Met Pathway.

  • Authors : Chen F; School of Life Sciences, Shanghai University, Shanghai, China.; Zheng Y

Subjects: Adenocarcinoma*/Adenocarcinoma*/Adenocarcinoma*/genetics ; Hepatocyte Growth Factor*/Hepatocyte Growth Factor*/Hepatocyte Growth Factor*/genetics ; Hepatocyte Growth Factor*/Hepatocyte Growth Factor*/Hepatocyte Growth Factor*/metabolism

  • Source: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2024 Apr; Vol. 39 (3), pp. 211-222. Date of Electronic Publication: 2022 Jul 08.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print-Electronic

Record details

×
Academic Journal

TIGD1 Is an Independent Prognostic Factor that Promotes the Progression of Colon Cancer.

  • Authors : Zou J; Department of Gastrointestinal Surgery, The Second Affiliated Hospital of Wannan Medical College, Wuhu, China.; Zhang H

Subjects: Colonic Neoplasms*/Colonic Neoplasms*/Colonic Neoplasms*/pathology; Humans ; Prognosis

  • Source: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2024 Apr; Vol. 39 (3), pp. 223-235. Date of Electronic Publication: 2022 Dec 12.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print-Electronic

Record details

×
Academic Journal

Knockdown of BUB1B Inhibits the Proliferation, Migration, and Invasion of Colorectal Cancer by Regulating the JNK/c-Jun Signaling Pathway.

  • Authors : Zeng Q; Department of Gastrointestinal Surgery, Yueyang Central Hospital, Yueyang, People's Republic of China.; Zhang S

Subjects: Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/pathology; Animals ; Mice

  • Source: Cancer biotherapy & radiopharmaceuticals [Cancer Biother Radiopharm] 2024 Apr; Vol. 39 (3), pp. 236-246. Date of Electronic Publication: 2023 Sep 29.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9605408 Publication Model: Print-Electronic

Record details

×
  • 1-10 of  8,718 results for ""Neoplasms""